{
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3792, 
        3806
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3905, 
        3928
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2766, 
        2793
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        477, 
        506
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2259, 
        2294
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2839, 
        2845
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3130, 
        3136
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3203, 
        3209
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3377, 
        3383
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3557, 
        3563
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3628, 
        3634
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3701, 
        3707
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3773, 
        3781
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2846, 
        2862
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3137, 
        3153
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3210, 
        3226
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3384, 
        3400
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3564, 
        3580
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3635, 
        3651
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3708, 
        3724
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3782, 
        3791
      ]
    }
  ], 
  "Relative Location (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2815, 
        2825
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2888, 
        2898
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2998, 
        3007
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3108, 
        3117
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3179, 
        3189
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3252, 
        3262
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3354, 
        3363
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3426, 
        3435
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3535, 
        3543
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3607, 
        3615
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3678, 
        3687
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3751, 
        3760
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2795, 
        2796
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 11^9311^MOH|PIMS|CCO|20160506101821|A85A9D8A1D8B480AFF287A54FEE0F15AC36DC6DE|ORU^R01|99999999999999999999|P|2.5|||||\nPID|1||^^^^MRN^HOSPITAL 11&9999&MOH~9999999999&KY&ON^^^^JHN||XXX^XXXX^XXXXX||99999999|M|||99 XXXXXXXX XXXXXXXX^^XXXXXXX^XX^X9X9X9^999|||||||||||||||||||N|\nOBR|1||BZ00604675|11529-5^Surgical Pathology Study Report^LN^BX^Biopsy^L|||20160427|||62254^XXXX^XXXXX^^^XX.||||||||||||20160506|||F|||||||99999^XXXXXXX^XXXXX^XXX^^XX|\n\n\n\n\n\n\n\nPath report.gross description\n\n1.Specimen consists of 1 tan tissue corenE\\measuring 15 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\2.Specimen consists of 1 tan tissue corenE\\measuring 12 mm and 1 fragment measuring in totalnE\\1 mm in length by less than 1 mm in diameter.nE\\Embedded in toto.nE\nE\\3.Specimen consists of 1 tan tissue corenE\\measuring 13 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\4.Specimen consists of 1 tan tissue corenE\\measuring 16 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\5.Specimen consists of 1 tan tissue corenE\\measuring 20 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\6.Specimen consists of 1 tan tissue corenE\\measuring 21 mm and 1 fragment measuring in totalnE\\1 mm in length by less than 1 mm in diameter.nE\\Embedded in toto.nE\nE\\7.Specimen consists of 1 tan tissue corenE\\measuring 11 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\8.Specimen consists of 2 tan tissue coresnE\\measuring 8 and 12 mm in length by less than 1 mmnE\\in diameter and no fragments. Embedded in toto.nE\nE\\9.Specimen consists of 1 tan tissue corenE\\measuring 16 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\10.Specimen consists of 1 tan tissue corenE\\measuring 15 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\11.Specimen consists of 1 tan tissue corenE\\measuring 18 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\12.Specimen consists of 1 tan tissue corenE\\measuring 13 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\\\n\n\nPath report.microscopic observation\n\nTumour TypenE\\Adenocarcinoma, conventional typenE\nE\\ExtentnE\\# sites involved/total sites  1 / 12nE\\# cores involved/total cores  1 / 12nE\\Overall % tissue involved  <1%nE\\% involvement in mostnE\\extensively involved core  10%nE\nE\\GleasonnE\\Overall Gleason Score (1?, worst)7 (3, 4)nE\\Highest Gleason Score (any site)7 (3, 4)nE\\% Gleason patterns 4, 5  N/A small focusnE\nE\\OthernE\\Perineural invasion     Not identifiednE\\Periprostatic fat invasion  Not identifiednE\\\n\n\nPath report.final diagnosis\n\n1.BIOPSY, PROSTATE (RIGHT BASE LATERAL)nE\\- BENIGN PROSTATIC TISSUE.nE\nE\\2.BIOPSY, PROSTATE (RIGHT BASE MEDIAL)nE\\- FOCAL PROSTATIC INTRAEPITHELIAL NEOPLASIAnE\\(PIN), HIGH GRADE.nE\nE\\3.BIOPSY, PROSTATE (RIGHT MID LATERAL)nE\\- FOCAL PROSTATIC INTRAEPITHELIAL NEOPLASIAnE\\(PIN), HIGH GRADE.nE\nE\\4.BIOPSY, PROSTATE (RIGHT MID MEDIAL)nE\\- BENIGN PROSTATIC TISSUE.nE\nE\\5.BIOPSY, PROSTATE (RIGHT APEX LATERAL)nE\\- BENIGN PROSTATIC TISSUE.nE\nE\\6.BIOPSY, PROSTATE (RIGHT APEX MEDIAL)nE\\- FOCAL CHRONIC INFLAMMATION, NEGATIVE FORnE\\MALIGNANCY.nE\nE\\7.BIOPSY, PROSTATE (LEFT BASE LATERAL)nE\\- BENIGN PROSTATIC TISSUE.nE\nE\\8.BIOPSY, PROSTATE (LEFT BASE MEDIAL)nE\\- FOCAL PROSTATIC INTRAEPITHELIAL NEOPLASIAnE\\(PIN), HIGH GRADE.nE\nE\\9.BIOPSY, PROSTATE (LEFT MID LATERAL)nE\\- BENIGN PROSTATIC TISSUE.nE\nE\\10.BIOPSY, PROSTATE (LEFT MID MEDIAL)nE\\- BENIGN PROSTATIC TISSUE.nE\nE\\11.BIOPSY, PROSTATE (LEFT APEX LATERAL)nE\\- BENIGN PROSTATIC TISSUE.nE\nE\\12.BIOPSY, PROSTATE (LEFT APEX MEDIAL)nE\\- INVASIVE PROSTATIC ADENOCARCINOMA; GLEASONnE\\SCORE 7/10 (PRIMARY 3, SECONDARY 4); 1/1 COREnE\\INVOLVED; 10% TISSUE INVOLVEMENT.nE\\\n\n\nPath report.relevant Hx\n\nPSA Total: 8.19 ng/mLnE\nE\\Other: High PSA, smooth prostatenE\\\n\n\n"
}